If you made any changes in Pure these will be visible here soon.

Personal profile


  • Ph.D. University of California, San Francisco

Research Interests

  • Pharmaceutical Management and Administration

Fingerprint Dive into the research topics where David Hui-Wen Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Trichomonas vaginalis Medicine & Life Sciences
Tritrichomonas foetus Medicine & Life Sciences
Thoracic Aorta Medicine & Life Sciences
Polygonum Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Deoxyribonucleosides Medicine & Life Sciences
Taiwan Agriculture & Biology
antihypertensive agents Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2014


Wang, L. & Cheng, D. H.


Project: A - Government Institutionc - Ministry of Health and Welfare

Research Output 1983 2018

  • 520 Citations
  • 15 h-Index
  • 36 Article
  • 1 Book
1 Citation (Scopus)
14 Citations (Scopus)

Periodic exposure to smartphone-mimic low-luminance blue light induces retina damage through Bcl-2/BAX-dependent apoptosis

Lin, C. H., Wu, M. R., Li, C. H., Cheng, H. W., Huang, S. H., Tsai, C. H., Lin, F. L., Ho, J. D., Kang, J. J., Hsiao, G. & Cheng, Y. W., May 1 2017, In : Toxicological Sciences. 157, 1, p. 196-210 15 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
Proton Pump Inhibitors
Gastrointestinal Diseases
Diabetes Mellitus
Cohort Studies
Retrospective Studies
5 Citations (Scopus)

Long-term Fluorometholone Topical Use Induces Ganglion Cell Damage in Rats Analyzed With Optical Coherence Tomography

Lin, C. H., Liao, P. L., Hsiao, G., Li, C. H., Huang, S. H., Tsai, C. H., Wu, M. R., Lin, F. L., Ho, J. D., Cheng, H. W. & Cheng, Y. W., Oct 1 2015, In : Toxicological Sciences. 147, 2, p. 317-325 9 p., kfv132.

Research output: Contribution to journalArticle

Optical tomography
Optical Coherence Tomography
19 Citations (Scopus)

Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: A 6-year follow-up study

Lin, H. C., Kachingwe, B. H., Lin, H. L., Cheng, H. W., Uang, Y. S. & Wang, L. H., 2014, In : Pharmacotherapy. 34, 1, p. 36-45 10 p.

Research output: Contribution to journalArticle

Risk Reduction Behavior
Type 2 Diabetes Mellitus
Hypoglycemic Agents